Viewing Study NCT03672292


Ignite Creation Date: 2025-12-24 @ 3:40 PM
Ignite Modification Date: 2026-01-01 @ 9:26 AM
Study NCT ID: NCT03672292
Status: TERMINATED
Last Update Posted: 2024-08-09
First Post: 2018-09-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis
Sponsor: Scynexis, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-01-22
Start Date Type: ACTUAL
Primary Completion Date: 2023-03-27
Primary Completion Date Type: ACTUAL
Completion Date: 2023-03-27
Completion Date Type: ACTUAL
First Submit Date: 2018-09-11
First Submit QC Date: None
Study First Post Date: 2018-09-14
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-05-15
Results First Submit QC Date: None
Results First Post Date: 2024-08-09
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-01
Last Update Post Date: 2024-08-09
Last Update Post Date Type: ACTUAL